Main Areas of Research

Professor Barclay is actively involved in a range of research projects in both Gastroenterology & Clinical Pharmacology, with collaborators in New Zealand, Australia, Europe & the United Kingdom. He has been awarded the University of Otago Christchurch Gold Medal for research.

  • Inflammatory Bowel Disease Icon Barclay Gastroenterology

    Inflammatory Bowel Disease

    - Causes
    - Epidemiology
    - Genetics
    - Drug Therapy 

  • Pharmacogenetics Icon Barclay Gastroenterology

    Pharmacogenetics

    How our genetic makeup affects how well a drug works and what side effects might occur.

  • Immunomodulator Drugs Icon Barclay Gastroenterology

    Immunomodulator Drugs

    Thiopurines and methotrexate, used to treat immune diseases like Inflammatory Bowel Disease and Rheumatoid Arthritis.

  • Monoclonal Antibody Drugs Icon Barclay Gastroenterology

    Monoclonal Antibody Drugs

    Infliximab and adalimumab are antibody drugs against tumour necrosis factor and are used in inflammatory bowel disease and other autoimmune diseases.

Publications

See Google Scholar Publications as below.